254 related articles for article (PubMed ID: 29092122)
1. Treatment of Prosthetic Valve Thrombosis with Bolus Dose Tenecteplase: An Experience from a Developing Country.
Kumar Jha R; Bansal S; S Issar H; Chaudhary M; Sharma S
J Heart Valve Dis; 2017 May; 26(3):349-354. PubMed ID: 29092122
[TBL] [Abstract][Full Text] [Related]
2. Obstructive Thrombosis of Left-Sided Mechanical Heart Valves: Clinical Profile and Thrombolytic Therapy.
Chandrakasu A; Jayachandran A; Gopinath Nayar P; Meyyappan C; Narayan G; Basha Abdul Bari A; Johnson Samuel P
J Heart Valve Dis; 2017 May; 26(3):344-348. PubMed ID: 29092121
[TBL] [Abstract][Full Text] [Related]
3. Tenecteplase versus streptokinase thrombolytic therapy in patients with mitral prosthetic valve thrombosis.
Kathirvel D; Justin Paul G; Prathap Kumar G; Palanisamy G; Gnanavelu G; Ravishankar G; Swaminathan N; Venkatesan S
Indian Heart J; 2018; 70(4):506-510. PubMed ID: 30170645
[TBL] [Abstract][Full Text] [Related]
4. Thrombolysis for Left-Sided Prosthetic Valve Thrombosis: Short- and Long-Term Outcomes.
Gupta S
J Heart Valve Dis; 2016 Mar; 25(2):214-220. PubMed ID: 27989070
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Anti-Tissue Type Plasminogen Activator Antibodies in Patients With Prosthetic Heart Valve Thrombosis: The ATA Trial.
Özkan M; Kalçık M; Gürsoy MO; Öcal L; Griffini S; Karakoyun S; Yesin M; Gündüz S; Astarcıoğlu MA; Bayam E; Cerşit S; Aykan AÇ; Cugno M
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):372-80. PubMed ID: 26657322
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial.
Özkan M; Gündüz S; Biteker M; Astarcioglu MA; Çevik C; Kaynak E; Yıldız M; Oğuz E; Aykan AÇ; Ertürk E; Karavelioğlu Y; Gökdeniz T; Kaya H; Gürsoy OM; Çakal B; Karakoyun S; Duran N; Özdemir N
JACC Cardiovasc Imaging; 2013 Feb; 6(2):206-16. PubMed ID: 23489534
[TBL] [Abstract][Full Text] [Related]
7. Use of tenecteplase in recurrent prosthetic valve thrombosis.
Hariram V; Sharma NP
J Heart Valve Dis; 2013 Nov; 22(6):872-3. PubMed ID: 24597413
[TBL] [Abstract][Full Text] [Related]
8. Use of tenecteplase for left-sided prosthetic valve thrombosis.
Sharma V; Singh R; Mishra R; Arora AP; Gupta LC; Yadava OP
J Assoc Physicians India; 2012 Dec; 60():55-8. PubMed ID: 23781674
[TBL] [Abstract][Full Text] [Related]
9. Thrombolytic treatment of prosthetic valve thrombosis: a study using Urokinase.
Huang F; Lan Y; Cheng Z; Zhang Z; Ren F
J Cardiothorac Surg; 2020 Oct; 15(1):286. PubMed ID: 33004057
[TBL] [Abstract][Full Text] [Related]
10. Successful use of Tenecteplase in a patient with recurrence of prosthetic mitral valve thrombosis.
Lahoti HA; Goyal BK
Indian Heart J; 2015 Dec; 67 Suppl 2(Suppl 2):S55-7. PubMed ID: 26688154
[TBL] [Abstract][Full Text] [Related]
11. Low-Dose and Slow-Infusion Thrombolysis for Prosthetic Valve Thrombosis After a Transcatheter Valve in the Mitral Position.
Roosen J; Haemers P; Verhamme P; Ameloot K; De Praetere H
JACC Cardiovasc Interv; 2017 Apr; 10(7):738-739. PubMed ID: 28330637
[No Abstract] [Full Text] [Related]
12. Successful fibrinolytic treatment of prosthetic heart valve thrombosis using streptokinase.
Sakr SA; Abdel-Shakour H; Ramadan MM
Acta Clin Belg; 2015 Jun; 70(3):159-66. PubMed ID: 25495280
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of patients with mitral prosthetic valve obstructive thrombosis treated with streptokinase or tenecteplase.
Kiran GR; Chandrasekhar P; Mohammad Ali S
Indian Heart J; 2021; 73(3):365-368. PubMed ID: 34154758
[TBL] [Abstract][Full Text] [Related]
14. Thrombolysis is superior to heparin for non-obstructive mitral mechanical valve thrombosis.
Lengyel M; Vegh G; Vandor L
J Heart Valve Dis; 1999 Mar; 8(2):167-73. PubMed ID: 10224577
[TBL] [Abstract][Full Text] [Related]
15. Thrombolysis of prosthetic mitral valve thrombosis in an infant.
Hage A; Jacques F; Chetaille P; Bourdages M; Cloutier K; Perron J; Houde C
J Card Surg; 2017 May; 32(5):310-312. PubMed ID: 28463467
[TBL] [Abstract][Full Text] [Related]
16. A Case Series of Obstructive Prosthetic Mitral Valve Thrombosis, Successfully Treated with Low-Dose, Slow Infusion Tissue-Type Plasminogen Activator.
Ari H; Dogan A; Ceviker K; Aksoy F; Arslan A; Varol E
J Heart Valve Dis; 2015 May; 24(3):353-9. PubMed ID: 26901912
[TBL] [Abstract][Full Text] [Related]
17. Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator.
Özkan M; Çakal B; Karakoyun S; Gürsoy OM; Çevik C; Kalçık M; Oğuz AE; Gündüz S; Astarcioglu MA; Aykan AÇ; Bayram Z; Biteker M; Kaynak E; Kahveci G; Duran NE; Yıldız M
Circulation; 2013 Jul; 128(5):532-40. PubMed ID: 23812180
[TBL] [Abstract][Full Text] [Related]
18. Thrombolytic Therapy for Right-Sided Mechanical Pulmonic and Tricuspid Valves: The Largest Survival Analysis to Date.
Taherkhani M; Hashemi SR; Hekmat M; Safi M; Taherkhani A; Movahed MR
Tex Heart Inst J; 2015 Dec; 42(6):543-7. PubMed ID: 26664307
[TBL] [Abstract][Full Text] [Related]
19. Thrombolytic therapy in prosthetic valve thrombosis during early pregnancy.
Srinivas BC; Moorthy N; Kuldeep A; Jeevan H; Chandrasekaran D; Manjunath CN
Indian Heart J; 2012; 64(1):74-6. PubMed ID: 22572429
[TBL] [Abstract][Full Text] [Related]
20. Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial.
Özkan M; Gündüz S; Gürsoy OM; Karakoyun S; Astarcıoğlu MA; Kalçık M; Aykan AÇ; Çakal B; Bayram Z; Oğuz AE; Ertürk E; Yesin M; Gökdeniz T; Duran NE; Yıldız M; Esen AM
Am Heart J; 2015 Aug; 170(2):409-18. PubMed ID: 26299240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
